Form 4 for DYN Dyne Therapeutics, Inc.
Accepted 2024-11-18 00:00:00 ET · period of report 2024-11-18 · accession 0000950170-24-128176 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-18 | 2024-11-18 | DYN | Incerti Carlo | Dir | M - OptEx | $8.69 | +16.5K | 16.5K | New | +$143.4K |
| D | 2024-11-18 | 2024-11-18 | DYN | Incerti Carlo | Dir | S - Sale+OE | $28.73 | -16.5K | 0 | -100% | -$474.0K |
| D | 2024-11-18 | 2024-11-18 | DYN | Incerti Carlo | Dir | M - OptEx | $0.00 | -16.5K | 22.7K | -42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-18 | M | A | 16,500 | $8.69 | 16,500 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-18 | S | D | 16,500 | $28.73 | 0 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $28.47 to $29.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4. |
| 3 | Derivative | Stock option (right to buy) | 2024-11-18 | M | D | 16,500 | $0.00 | 22,693 | D | $8.69 · — to 2032-03-01 | 16,500 Common Stock | (F2) The option was granted on March 2, 2022. The shares underlying the option are scheduled to vest over three years in equal monthly installments through March 2, 2025. |